k11-Anemia Defisiensi Besi
-
Upload
agus-salim-bhr -
Category
Documents
-
view
242 -
download
0
Transcript of k11-Anemia Defisiensi Besi
-
8/6/2019 k11-Anemia Defisiensi Besi
1/37
1
HEMATOLOGY -ONCOLOGY DiChild Health Depart.- School of Medicine
University of Sumatera Utara
-
8/6/2019 k11-Anemia Defisiensi Besi
2/37
Anemia
Definition:
reduction in red cell mass or blood
hemoglobin concentration below 2standard deviations (SD)
2
-
8/6/2019 k11-Anemia Defisiensi Besi
3/37
T able 1.Normal red blood cell values in children
Hemoglobin(g/dl) MCV(fl)Age Mean -2SD Mean -2SDBirth (cord blood) 16.5 13.5 108 981-3 days(capillary) 18.5 14.5 108 951 week 17.5 13.5 107 882 week 16.5 12.5 105 861 month 14.0 10.0 104 852 month 11.5 9.0 96 773-6 month 11.5 9.5 91 740.5-2 years 12.0 10.5 78 702-6 years 12.5 11.5 81 756-12 years 13.5 11.5 86 77
12-18 years, female 14.0 12.0 90 7812-18 years, male 14.5 13.0 88 7818-49 years, female 14.0 12.0 90 8018-49 years, male 15.5 13.5 90 80
Caroline Hasting,2002
3
-
8/6/2019 k11-Anemia Defisiensi Besi
4/37
4
IRO N DEF I C I ENCY ANEM I A
Definition :Anemia resulting from lack of sufficient iron forsynthesis of hemoglobin.
Pr evalence : The most common cause of anemia worlwide
An estimated 30% of the world s population :4.5 billion @ anemic500 600 million @ Iron def. anemia
-
8/6/2019 k11-Anemia Defisiensi Besi
5/37
5
P revalenceP revalence
Anemia Anemia
Developed countries0-4 tahun : 20.1%5-14 tahun: 5.9%
Developing countries0-4 tahun: 39.0%5-14 tahun: 48.1%
WHO, 2001
-
8/6/2019 k11-Anemia Defisiensi Besi
6/37
6
P revalenceP revalenceof ID & IDAof ID & IDA
USA:1-2 years ID 9%; IDA 3%adolescent girls ID 9%; IDA 2%UK Infants:
Asian IDA 39% Afro-Caribbean 20%White 16%
Developing countries
Adolescent girls 21-35%
Indonesia (SKRT 2001):
-
8/6/2019 k11-Anemia Defisiensi Besi
7/37
7
Etiology of iron deficiency
-
8/6/2019 k11-Anemia Defisiensi Besi
8/37
ETIOLOGY
I. Deficiency intake :
Dietary (milk 0,5-1.5 mg iron/L)
II. Increased demand :Growth (low birth weight, premarurity, low-birth-weight twins or multiple births, adolescence,pregnancy)Cyanotic Congenital heart disease
III. Blood loss :A. Perinatal
1. PlacentalTransplacental bleeding into maternal circulationRetroplacental (e.g,premature placental separatio )IntraplacentalFetal blood loss or before birth (e.g, placenta previa)Fetofetal bleeding in monochrorionic twinsPlacental abnormalities 8
-
8/6/2019 k11-Anemia Defisiensi Besi
9/37
. 2.Umbilicus- Ruptured umbilical cord (e.g, vasa previa) and
other umbilical cord abnormalities
- Inadequate cord tying- Postexchange transfusion
B. Postnatal1.Gastrointestinal tract
- Primary iron deficiency anemia resulting in gutalterationwith blood loss agravating existing iron deficiency- Hypersensitivity to whole cows milk?
- Anatomic gut lesions, exudative enteropathycaused by undelying bowel disease
- Gastritis from aspirin, adrenocortical steroids,indomethacin, phenylbutazone
- Intestinal parasites( e.g, hookworm /N ecator Americanus )- Henoch-Scholein Purpura
9
-
8/6/2019 k11-Anemia Defisiensi Besi
10/37
2. Hepatobililiary system: hematobilia3. Lung: Pulmonary hemosiderosis, Goodpasture
sydrome, defective iron mobilization with IgA deficiency4. Nose: recurrent epistaxis5. Uterus: menstrual loss6. Heart: intracardiac myxomata, valvular prostheses or
patches7. Kidney: microangiopathic hemolytic anemia, hematuria,
nephrotic syndrome,hemosiderinurias-chronicintravascular hemolysis
8. Extracorporeal: hemodialysis, trauma
IV. Imparied absorptionMalabsorption syndrome, celiac disease, severeprolonged diarrhea, postgastrectomy, inflammatorybowel disease, H elicobacter pylori infection associatedchronic gastritis
Lanzkowsky ,200 5
10
-
8/6/2019 k11-Anemia Defisiensi Besi
11/37
11
K ey Functional of I ron
-
8/6/2019 k11-Anemia Defisiensi Besi
12/37
12
I ron Status in Human Body
-
8/6/2019 k11-Anemia Defisiensi Besi
13/37
-
8/6/2019 k11-Anemia Defisiensi Besi
14/37
1414
-
8/6/2019 k11-Anemia Defisiensi Besi
15/37
-
8/6/2019 k11-Anemia Defisiensi Besi
16/37
History takingP allor,floppiness :time of onsetFatigue,lethargyP oor feedingIrritabilityAbdominal painHeadache ,dizzinessShortness of breathArthralgia
1 6
-
8/6/2019 k11-Anemia Defisiensi Besi
17/37
Clinical Manifestation
P allor ,jaundice T ac h ycardia ,p ostural h ypotension A norexia A ngular stomatitis G lossitis S poon nail
Pica (pago ph agia) E ff ect on neurologic and intellectual f unction: attention s pan , allertness ,learning
N athan Osk i,2003Lanz kow sky P,2005Glade r B, 2007
1 7
-
8/6/2019 k11-Anemia Defisiensi Besi
18/37
CLINICAL MANIFESTATIONS
M ild moderate iron de f. ( Hb 6- 10 g/dl) @ com pensatory mec h anism (+)
S evere iron de f iciency (Hb < 5 g/dl) : F atigue , listlessness , irritability,anorexia , tac h ycardia , cardiac dilatation & systolic murmurs .- A dvanced iron de f iciency :
P ale , p lum p, & p etulant
18
-
8/6/2019 k11-Anemia Defisiensi Besi
19/37
N onhematologic con sequence : P ica :
Ph ago ph agia (com pulsive eating of ice) G eo ph agia : interest in dirt consum ption @ risk f or
parasitic inf estation & lead poisoning) E ph itelial c h anges : Koilonyc h ia , atro ph y of lingual pa pil
E xercise intolerance B e h avioral ch anges
A bnormal th ermogenesis A ltered h ost res ponse
M iller Rd,Baehner RL,edisi ke 7
CLINICAL M ANIFESTATIONS
1 9
-
8/6/2019 k11-Anemia Defisiensi Besi
20/37
20
-
8/6/2019 k11-Anemia Defisiensi Besi
21/37
21
LABORATORIUM FINDINGS
Hemoglobin(Hb) is below the acceptable level for ageRed cell indices :- / normal MCV ,MC HC and MC HC for age- RDW
Blood smear :- Red cells : hypochromic, microcytic with anisocytosisand poikilocytosis Hb concentration
Reticulocyte count: N/slightly increasedP leated count : Thrombocytopenia, thrombocytosisFree erythrocyte protoporphyrin: > 100 g/dl
-
8/6/2019 k11-Anemia Defisiensi Besi
22/37
Lab .finding
Consentration Ferritin <
12 mg/dl S erum iron and iron saturation percentage iron
metabolism : S erum iron : TI BC :
T
rans f errin sat . (ratio SI
: TI
BC
) : S erum trans f errin rece ptor levels ( ST fR )Red blood cell zinc proto por ph yrin/ h eme ratio - Bone marrow iron is insu ff icient to su pp ort h eme synt h esis
- Zinc proto por ph rin relative to h eme increases- Zinc substituses f or iron in proto por ph yrin IX
22
-
8/6/2019 k11-Anemia Defisiensi Besi
23/37
T he diagnosis of microcitic anemia usingMCV and R DW
MCV
Low
RDW
Narrow Wide
Hb elektroforesis FE P*MCV on P arents Ferritin
Trial of Iron* Also elevated in lead poisonin. Do serum lead level (if clinical indicated)
23
-
8/6/2019 k11-Anemia Defisiensi Besi
24/37
24
-
8/6/2019 k11-Anemia Defisiensi Besi
25/37
2 5P oikylocytosis Anisocytosis
-
8/6/2019 k11-Anemia Defisiensi Besi
26/37
2 6
DIFFERENTIAL DIAGNOSIS
1.Thalassemia trait
2.Anemia of chronic diseases3.Lead poisoning
-
8/6/2019 k11-Anemia Defisiensi Besi
27/37
2 7
Diffrential Diagnosis Hypochrom MicrocyticAnemia
Lab finding s IDA Thala ss emia Mino r Anemia ch r onic di sea se
MCV N/Serum iron N
TIBC NTransferrin saturation N N/FEP NSerum ferritin N
Lukens,1995
-
8/6/2019 k11-Anemia Defisiensi Besi
28/37
28
Criteria of IDA by WHO :1. Hb concentration < normal (age dependent)2. Hematocrit < 31% ( N: 32 - 35%)3. Serum iron < 50 Ug/dl (N: 80-180 ug/dl)4. Transferrin sat. < 15 (N: 20-50%)
-
8/6/2019 k11-Anemia Defisiensi Besi
29/37
2 9
...Diagnosis
Alternative way to determine IDA:
Tr ial of ir on supplementation
Important to know subclinical IDA with monitorhemoglobin respons (increased hemoglobin level).This procedure is very practical, sensitive daneconomical especially for children at high risk of IDA
If with iron supplementation 3 mg iron/kgBW/day, 3-4weeks, Hb level is increased 1-2 g/dL it is confirmedfor IDA.
-
8/6/2019 k11-Anemia Defisiensi Besi
30/37
30
Classification of A nemia
S creening Hb CBC:
M CV- M CH
M icrocytic, h ypoc h romic
MCV
-
8/6/2019 k11-Anemia Defisiensi Besi
31/37
C linical management
D iagnosis Assessment of underlying cause : dietary h istory ,birth h istory , p resence of abnormal bleeding ,
f amily h istory , p ast medical/surgery h istoryInvestigation and treatment : dietary advice ,endosco pyIron therapy
31
-
8/6/2019 k11-Anemia Defisiensi Besi
32/37
Ir on the r ap y
Oral therapyD ose: 3 mg/kg/day (2 devided doses) max 180 mgD uration: 6-8 weeks a f ter Hb and th e red cell indices return normalTh e f ollowing pre parations provide 3 mg of elemental iron: 1 5 mg of f errous sul f ate ,
9 mg of f errous f umarate ,2 6 mg of f errous gluconate ,
9 mg of f errous succinate ,1 7 mg of f errous glycine sul f ate ,21 mg of sodium iron edetate
32
-
8/6/2019 k11-Anemia Defisiensi Besi
33/37
Parenteral Therapy
1 .Intramuscular Iron dextran ( 50 mg elemental iron/ml) /im , with dose :
Normal Hb - initial Hb x Blood volume (ml)x 3 .4 x 1 .5100
2 .Intravenous.S odium f erric gluconate (Ferrlecit)
.Iron (III) h ydroxyde sucrose com ple (Veno f er)A nemia associated with renal f ailure and h emodialysisD ose: 1 4 mg/ Kg/week
33
-
8/6/2019 k11-Anemia Defisiensi Besi
34/37
Tr an sfu sion the r ap y
P acked red cell S
evere anemia (Hb < 5 g/dl) requiring correction more ra pidly es pecially wh en signs of cardiac dys f unction are present
34
-
8/6/2019 k11-Anemia Defisiensi Besi
35/37
Factors affecting iron absorption of nonhemeiron from the gastrointestinal tract
Increased absorptionVit C: citrus, tomatoes, potatoes,SolutesSugarsmeat, fish,poultryHydrochloric acidD ecreased absorptionAntacidsP ancreatic secretionsHypochlorhydriaP hytatesP hosphates
Blackwell,2006
3 5
-
8/6/2019 k11-Anemia Defisiensi Besi
36/37
Prevention
1 .E ncouragement of breast f eeding (BF )2 .Use of iron- f ortif ied inf ant f ormula a f ter weaning
BF or non- BF3 .D elay in th e introduction of wh ole cows milk to 1
year of age4 .Use iron f orti f ied inf ant cereals and ascorbic
acid-rich
f ood solid f ood are introduced at 6 mont h s5. S upp lemental iron
3 6
-
8/6/2019 k11-Anemia Defisiensi Besi
37/37
.. Pr evention
Ir on supplemental :
E xclusive breast f eeding beyond 6 mont h : 1 mg/ Kg/d
Low birth weig h t inf ants:a . 1 .5 -2 .0 kg : 2 mg/kg/dayb. 1 .0 -1 .5 kg : 3 mg/kg/dayc.